|
Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG) Clinical Trials
1 actively recruiting trial across 1 location
Also known as: HP C13-aKG, Hyperpolarized C13-aKG
San Francisco, California1 trial
Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma
University of California, San Francisco
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.